Decision Aid for Breast Cancer Surgery Choices
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a web-based tool designed to assist patients with newly diagnosed stage 0-III breast cancer in making informed decisions about their surgery options. Researchers aim to determine if the tool increases patient engagement in the decision-making process. They are also investigating whether individuals from disadvantaged backgrounds encounter more challenges despite this aid. Suitable candidates for this trial are those planning breast surgery as part of their treatment and who are comfortable discussing their options in English. As an unphased study, this trial allows patients to contribute to research that could improve decision-making tools for future breast cancer patients.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this decision aid is safe for patients with breast cancer?
Research has shown that online decision-making tools are generally safe and easy to use. Studies indicate they can increase breast cancer patients' satisfaction with their surgery choices, leading to greater confidence in their decisions. One study found that these tools can also enhance decision-making quality after a mastectomy. No reports have indicated any problems caused by these online tools, which are designed to assist patients without causing harm.12345
Why are researchers excited about this trial?
Researchers are excited about the web-based decision aid for breast cancer surgery choices because it offers a personalized approach to help patients make informed decisions about their treatment options. Unlike the traditional method, where patients rely mainly on in-person consultations with their surgeons, this digital tool provides tailored information and support before the surgical consultation. This innovative approach empowers patients by giving them more time to understand their choices, potentially reducing anxiety and leading to more satisfactory treatment outcomes.
What evidence suggests that this web-based decision aid is effective for increasing patient engagement in breast cancer surgery choices?
Research has shown that online tools can assist breast cancer patients in making surgical decisions. In this trial, participants in one arm will receive a web-based decision aid before their surgical consultation. Several studies have found that these tools increase satisfaction with decisions, enhancing patients' confidence and clarity about their choices. One study found that patients using an online tool felt less uncertain about their decisions. Another study demonstrated that these tools offer benefits beyond regular care, improving the quality of decision-making. Overall, online tools help patients make informed choices about their breast cancer treatment.12467
Who Is on the Research Team?
Heather B. Neuman,, MD, MS
Principal Investigator
University of Wisconsin, Madison
Are You a Good Fit for This Trial?
This trial is for English-speaking patients newly diagnosed with stage 0-III breast cancer who are planning surgery as part of their treatment. Surgeons and care staff at participating clinics must consent to the study. Patients with impaired decision-making capacity or hearing impairment requiring an interpreter are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Usual Care
Participants receive care as per usual practice before institutional crossover
Decision Aid Intervention
Participants receive a web-based decision aid prior to surgical consultation after institutional crossover
Follow-up
Participants are monitored for patient engagement and knowledge post-surgical consultation
What Are the Treatments Tested in This Trial?
Interventions
- Web-based decision aid
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alliance for Clinical Trials in Oncology
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Agency for Healthcare Research and Quality (AHRQ)
Collaborator